| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |